- Trials with a EudraCT protocol (225)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
225 result(s) found for: Psychiatric interview.
Displaying page 1 of 12.
EudraCT Number: 2005-005708-17 | Sponsor Protocol Number: ELB139202-05 | Start Date*: 2006-03-27 | |||||||||||
Sponsor Name:elbion AG | |||||||||||||
Full Title: International, multicenter, randomized, double-blind, placebo controlled, two-period, cross-over study to demonstrate safety, tolerability and anxiolytic effects of 600 mg ELB139 given orally t.i.d... | |||||||||||||
Medical condition: Male and female patients with diagnosis of concurrent panic disorder according to DSM-IV, with or without agoraphobia (DSM IV 300.21 and 300.1) according to Mini International Neuropsychiatric Inte... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013028-21 | Sponsor Protocol Number: ------ | Start Date*: 2009-10-16 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE | |||||||||||||
Full Title: USE OF CLINICAL AND INTERMEDIATE PHENOTYPES TO ASSESS RESPONSE TO QUETIAPINE: THE ROLE OF PUTATIVE CAUSATIVE GENES | |||||||||||||
Medical condition: schizophrenia using the Structured Clinical Interview for Diagnosis (SCID) for the Diagnostic and Statistical Manual of Mental Disorders- Fourth Edition (DSM-IV); | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001523-39 | Sponsor Protocol Number: D1050300 | Start Date*: 2013-11-08 | |||||||||||
Sponsor Name:Sunovion Pharmaceuticals Inc. | |||||||||||||
Full Title: A PHASE 1 OPEN-LABEL, MULTICENTER, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF LURASIDONE IN SUBJECTS 6 TO 17 YEARS OLD WITH SCHIZOPHRENIA SPE... | |||||||||||||
Medical condition: schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000757-13 | Sponsor Protocol Number: RGH-MD-54 | Start Date*: 2016-06-07 | |||||||||||
Sponsor Name:Forest Laboratories LLC, an Allergan Affiliate | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipo... | |||||||||||||
Medical condition: Bipolar I Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) LT (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010625-39 | Sponsor Protocol Number: MZ09-PCP-SosPeter | Start Date*: 2010-04-21 |
Sponsor Name:Prague Psychiatric Center | ||
Full Title: QEEG cordance and EEG connectivity changes after administration of subanesthetic ketamine doses in depressive disorder patients | ||
Medical condition: INCLUSION CRITERIA: 1. Men and women at the age between 18 to 65 years, with dextromanual dominance. 2. Patients have to answer DSM IV criteria for the major depressive episode, without psychotic s... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000756-98 | Sponsor Protocol Number: RGH-MD-53 | Start Date*: 2016-07-19 | |||||||||||
Sponsor Name:Forest Laboratories LLC, an Allergan Affiliate | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipo... | |||||||||||||
Medical condition: Bipolar I Depression | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) HR (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000089-11 | Sponsor Protocol Number: AX-CL-09 | Start Date*: 2004-12-15 |
Sponsor Name:Axonyx Inc | ||
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of phenserine-tartrate in patients with probable mild to moderate Alzheimer’s disease | ||
Medical condition: Alzheimer's Disease is caused by a loss of nerve cells in the brain, particularly in the areas associated with memory and learning. The onset of Alzheimer's also affects the levels of a certain neu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004460-63 | Sponsor Protocol Number: EXPO | Start Date*: 2019-07-01 | ||||||||||||||||
Sponsor Name:South London and Maudsley NHS Foundation Trust [...] | ||||||||||||||||||
Full Title: Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO): An Open Label Randomised Controlled Trial of Injectable Depot Maintenance Buprenorphine versus Standard-Of-Care Oral Maintenance Opi... | ||||||||||||||||||
Medical condition: Opiod addiction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011097-15 | Sponsor Protocol Number: OLA_ZIPRA | Start Date*: 2009-08-25 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie | ||
Full Title: Effect of atypical antipsychotics on gene expression in soft tissues of healthy subjects. A placebo controlled randomised pilot study. | ||
Medical condition: The study will be conducted in 42 healthy volunteers | ||
Disease: | ||
Population Age: | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002859-19 | Sponsor Protocol Number: 072016 | Start Date*: 2017-08-22 |
Sponsor Name:Erasmus MC | ||
Full Title: Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail? | ||
Medical condition: People with challenging behavior and off-label antipsychotic use | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003076-22 | Sponsor Protocol Number: PSY-201401_ESPRIT | Start Date*: 2016-07-07 | ||||||||||||||||
Sponsor Name:Central Institute of Mental Health Mannheim (ZI) | ||||||||||||||||||
Full Title: Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trial investigating the efficacy of Acetylcysteine (ACC) and Integrated Preventive Psychological Intervention (IPPI) in... | ||||||||||||||||||
Medical condition: Clinical High Risk state for developing a first psychotic episode | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001529-24 | Sponsor Protocol Number: 190-062 | Start Date*: 2007-03-06 | |||||||||||
Sponsor Name:Sepracor NV in care of Sepracor Inc. | |||||||||||||
Full Title: Adults adminstered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects wit... | |||||||||||||
Medical condition: Insomnia Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) SE (Completed) GB (Completed) FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000933-12 | Sponsor Protocol Number: AX-CL-10 | Start Date*: 2005-02-22 |
Sponsor Name:Axonyx Inc | ||
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of phenserine-tartrate in patients with probable mild to moderate Alzheimer’s disease | ||
Medical condition: Alzheimers disease is caused by a loss of nerve cells in the brain, particularly in the areas associated with memory and learning. The onset of Alzheimers's also affects the levels of a certain neu... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004049-19 | Sponsor Protocol Number: NL77938.018.23 | Start Date*: 2023-10-13 |
Sponsor Name:Amsterdam UMC | ||
Full Title: Sodium oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomized controlled trial. The Laborit study. | ||
Medical condition: Catatonia in patients with depression, bipolar disorder or a psychotic disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001518-40 | Sponsor Protocol Number: 848040001 | Start Date*: 2020-01-31 |
Sponsor Name:VU Medical Center | ||
Full Title: Netherlands study of Optimal, PERsonalized Antidepressant use (OPERA-DISCONTINUATION) | ||
Medical condition: Depression | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002326-36 | Sponsor Protocol Number: 2016-858 | Start Date*: 2016-11-09 | ||||||||||||||||
Sponsor Name:Region Hovedstadens psykiatriske hospital | ||||||||||||||||||
Full Title: Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T) | ||||||||||||||||||
Medical condition: Unipolar/bipolar depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003789-25 | Sponsor Protocol Number: mela1 | Start Date*: 2015-02-26 | |||||||||||
Sponsor Name:Department of surgery, Herlev Hospital | |||||||||||||
Full Title: The anxiolytic effects of melatonin: A randomized, placebo-controlled, double-blinded clinical study. | |||||||||||||
Medical condition: We intend to investigate the anxiolytic effects of melatonin in relation to surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000952-17 | Sponsor Protocol Number: NT13403 | Start Date*: 2013-04-29 | |||||||||||
Sponsor Name:Prague Psychiatric Centre | |||||||||||||
Full Title: The Role of mTOR (Mammalian Target of Rapamycin) Signaling Pathway in the Antidepressive Effect of Ketamine in Patients with Depressive Disorder. | |||||||||||||
Medical condition: 1. Men and women at the age between 18 to 65 years, with dextromanual dominance. 2. Patients have to answer DSM IV criteria for the major depressive episode, without psychotic symptoms, on the clin... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004054-28 | Sponsor Protocol Number: Panorexia | Start Date*: 2020-06-23 | ||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||
Full Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study | ||||||||||||||||||
Medical condition: Anorexia Nervosa | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006108-34 | Sponsor Protocol Number: 10140021910006 | Start Date*: 2022-09-29 | ||||||||||||||||||||||||||
Sponsor Name:AmsterdamUMC (location VUmc) | ||||||||||||||||||||||||||||
Full Title: Trial Examining Methods for Antidepressant Discontinuation | ||||||||||||||||||||||||||||
Medical condition: Major Depressive Disorder | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
